3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
9
OTHER
6
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Recurrent Squamous Cell Lung Carcinoma
2
Melanoma
2
Small Cell Lung Carcinoma
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Inoperable Åsophageal Cancer
1
Gastric and Esophagogastric Junction Adenocarcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Diabetes Mellitus, Insulin-Dependent, 12
×
Ipilimumab
×
Clear all
NCT02046733
2024-11-08
STIMULI
ETOP IBCSG Partners Foundation
Phase 2
Completed
222 enrolled
18 charts